Literature DB >> 24041951

Evaluating the Framingham hypertension risk prediction model in young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) study.

April P Carson1, Cora E Lewis, David R Jacobs, Carmen A Peralta, Lyn M Steffen, Julie K Bower, Sharina D Person, Paul Muntner.   

Abstract

A prediction model was developed in the Framingham Heart Study (FHS) to evaluate the short-term risk of hypertension. Our goal was to determine the predictive ability of the FHS hypertension model in a cohort of young adults advancing into middle age and compare it with the predictive ability of prehypertension and individual components of the FHS model. We studied 4388 participants, aged 18 to 30 years without hypertension at baseline, enrolled in the Coronary Artery Risk Development in Young Adults (CARDIA) Study, who participated in 2 consecutive examinations occurring 5 years apart between the baseline (1985-1986) and year 25 examination (2010-2011). Weibull regression was used to assess the association of the FHS model overall, individual components of the FHS model, and prehypertension with incident hypertension. During the 25-year follow-up period, 1179 participants developed incident hypertension. The FHS hypertension model (c-index=0.84; 95% confidence interval, 0.83-0.85) performed well in discriminating those who did and did not develop hypertension and was better than prehypertension alone (c-index=0.71; 95% confidence interval, 0.70-0.73). The predicted risk from the FHS hypertension model was systematically lower than the observed hypertension incidence initially (χ(2)=249.4; P<0.001) but demonstrated a good fit after recalibration (χ(2)=14.6; P=0.067). In summary, the FHS model performed better than prehypertension and may be a useful tool for identifying young adults with a high risk for developing hypertension.

Entities:  

Keywords:  epidemiology; hypertension; prehypertension; risk

Mesh:

Year:  2013        PMID: 24041951      PMCID: PMC4019674          DOI: 10.1161/HYPERTENSIONAHA.113.01539

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  25 in total

1.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

Authors:  R B D'Agostino; S Grundy; L M Sullivan; P Wilson
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

Review 2.  A comparison of goodness-of-fit tests for the logistic regression model.

Authors:  D W Hosmer; T Hosmer; S Le Cessie; S Lemeshow
Journal:  Stat Med       Date:  1997-05-15       Impact factor: 2.373

3.  Comparison of the Framingham Heart Study hypertension model with blood pressure alone in the prediction of risk of hypertension: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Paul Muntner; Mark Woodward; Devin M Mann; Daichi Shimbo; Erin D Michos; Roger S Blumenthal; April P Carson; Haiying Chen; Donna K Arnett
Journal:  Hypertension       Date:  2010-05-03       Impact factor: 10.190

4.  Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000.

Authors:  Kurt J Greenlund; Janet B Croft; George A Mensah
Journal:  Arch Intern Med       Date:  2004-10-25

5.  Ethnic differences in hypertension incidence among middle-aged and older adults: the multi-ethnic study of atherosclerosis.

Authors:  April P Carson; George Howard; Gregory L Burke; Steven Shea; Emily B Levitan; Paul Muntner
Journal:  Hypertension       Date:  2011-04-18       Impact factor: 10.190

6.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

7.  Feasibility of treating prehypertension with an angiotensin-receptor blocker.

Authors:  Stevo Julius; Shawna D Nesbitt; Brent M Egan; Michael A Weber; Eric L Michelson; Niko Kaciroti; Henry R Black; Richard H Grimm; Franz H Messerli; Suzanne Oparil; M Anthony Schork
Journal:  N Engl J Med       Date:  2006-03-14       Impact factor: 91.245

8.  Hypertension awareness, treatment, and control--continued disparities in adults: United States, 2005-2006.

Authors:  Yechiam Ostchega; Sung S Yoon; Jeffery Hughes; Tatiana Louis
Journal:  NCHS Data Brief       Date:  2008-01

Review 9.  Prehypertension: risk stratification and management considerations.

Authors:  Brent M Egan; Stevo Julius
Journal:  Curr Hypertens Rep       Date:  2008-10       Impact factor: 5.369

10.  The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.

Authors:  Stephan Lüders; Joachim Schrader; Jürgen Berger; Thomas Unger; Walter Zidek; Michael Böhm; Martin Middeke; Wolfgang Motz; Cornelia Lübcke; Andrea Gansz; Ludmer Brokamp; Roland E Schmieder; Peter Trenkwalder; Herrmann Haller; Peter Dominiak
Journal:  J Hypertens       Date:  2008-07       Impact factor: 4.844

View more
  12 in total

1.  Association of Blood Pressure Classification in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Cardiovascular Events Later in Life.

Authors:  Yuichiro Yano; Jared P Reis; Laura A Colangelo; Daichi Shimbo; Anthony J Viera; Norrina B Allen; Samuel S Gidding; Adam P Bress; Philip Greenland; Paul Muntner; Donald M Lloyd-Jones
Journal:  JAMA       Date:  2018-11-06       Impact factor: 56.272

Review 2.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

3.  Development and validation of hypertension prediction models: The Korean Genome and Epidemiology Study_Cardiovascular Disease Association Study (KoGES_CAVAS).

Authors:  Hyun Kyung Namgung; Hye Won Woo; Jinho Shin; Min-Ho Shin; Sang Baek Koh; Hyeon Chang Kim; Yu-Mi Kim; Mi Kyung Kim
Journal:  J Hum Hypertens       Date:  2022-02-18       Impact factor: 3.012

4.  Do Short Spurts of Physical Activity Benefit Cardiovascular Health? The CARDIA Study.

Authors:  Daniel K White; Kelley Pettee Gabriel; Yongin Kim; Cora E Lewis; Barbara Sternfeld
Journal:  Med Sci Sports Exerc       Date:  2015-11

5.  Modifiable Risk Factors Versus Age on Developing High Predicted Cardiovascular Disease Risk in Blacks.

Authors:  Adam P Bress; Lisandro D Colantonio; John N Booth; Tanya M Spruill; Joseph Ravenell; Mark Butler; Amanda J Shallcross; Samantha R Seals; Kristi Reynolds; Gbenga Ogedegbe; Daichi Shimbo; Paul Muntner
Journal:  J Am Heart Assoc       Date:  2017-02-08       Impact factor: 5.501

Review 6.  Recent development of risk-prediction models for incident hypertension: An updated systematic review.

Authors:  Dongdong Sun; Jielin Liu; Lei Xiao; Ya Liu; Zuoguang Wang; Chuang Li; Yongxin Jin; Qiong Zhao; Shaojun Wen
Journal:  PLoS One       Date:  2017-10-30       Impact factor: 3.240

7.  Validation of the Framingham hypertension risk score in a middle eastern population: Tehran lipid and glucose study (TLGS).

Authors:  Fatemeh Koohi; Ewout W Steyerberg; Leila Cheraghi; Alireza Abdshah; Fereidoun Azizi; Davood Khalili
Journal:  BMC Public Health       Date:  2021-04-24       Impact factor: 3.295

8.  Identifying drug-related attributes to personalise antihypertensive agents: the outcome report of patients receiving metoprolol therapy.

Authors:  Chunyu Liu; Jing Xu; Ran Liu; Miye Wang; Yixuan Zhuo; Lan Su; Hongmei Yan; Qing Zhang
Journal:  BMC Med Inform Decis Mak       Date:  2021-12-30       Impact factor: 2.796

9.  Development and validation of prediction models for hypertension risks in rural Chinese populations.

Authors:  Fei Xu; Jicun Zhu; Nan Sun; Lu Wang; Chen Xie; Qixin Tang; Xiangjie Mao; Xianzhi Fu; Anna Brickell; Yibin Hao; Changqing Sun
Journal:  J Glob Health       Date:  2019-12       Impact factor: 4.413

10.  A risk scoring system to predict the risk of new-onset hypertension among patients with type 2 diabetes.

Authors:  Cheng-Chieh Lin; Chia-Ing Li; Chiu-Shong Liu; Chih-Hsueh Lin; Mu-Cyun Wang; Shing-Yu Yang; Tsai-Chung Li
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-07-12       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.